**AI独角兽云知声重启港股IPO，累计亏损近5亿元，京东、360等名企参投**
中国领先的AI企业云知声智能科技股份有限公司（简称“云知声”）近期更新了其在港交所主板上市的招股书，标志着该公司第二次尝试登陆资本市场，中金公司和海通国际担任联席保荐人。此前，云知声在2020年11月曾向科创板提交上市申请，但于3个月后终止了该计划。
尽管云知声在其发展历程中累计亏损近5亿元，但其强大的投资者阵容仍显示了市场对其前景的看好。投资者包括启明创投、挚信资本、磐谷创投、中网投、京东、中电健康基金、中金公司、360集团以及高通等知名机构。这些投资者的参与，无疑为云知声的研发和市场拓展提供了坚实的资金支持。
值得一提的是，云知声在2023年推出了具有600亿参数的“山海”大模型，目前模型参数规模已迭代至千亿级别。公司计划将这一先进的大模型技术应用于智慧生活和智慧医疗领域，这预示着云知声在AI技术创新和商业化应用上将有更大的突破。
云知声的上市之路虽有波折，但其在AI领域的技术积累和市场潜力，以及众多重量级投资者的背书，都为其未来的发展注入了信心。随着AI技术的不断演进，云知声有望在智慧医疗和智慧生活等关键领域实现更大的商业价值。
英语如下：
**News Title:** “Unicorn AI Company Yunzhisheng Re-Launches Hong Kong IPO: Near 500 Million Loss, Backed by Tech Giants like JD.com and 360”
**Keywords:** Yunzhisheng, Hong Kong IPO, AI Unicorn
**News Content:**
Chinese AI pioneer Yunzhisheng Intelligent Technology Co., Ltd. (referred to as “Yunzhisheng”) has recently updated its listing prospectus for the main board of the Hong Kong Stock Exchange, signaling a second attempt to enter the capital market. CICC and Haitong International are joint sponsors for the IPO. Previously, in November 2020, Yunzhisheng submitted an application to list on the STAR Market but withdrew the plan three months later.
Despite cumulative losses of nearly 500 million yuan during its development, Yunzhisheng’s impressive investor lineup indicates optimism about its future prospects. Investors include Qiming Venture Partners, TrustBridge Capital, PanGu Venture Capital, China Internet Plus Capital, JD.com, China Electronics Health Fund, CICC, Qihoo 360, and Qualcomm, among other renowned institutions. These investors’ backing provides a solid financial foundation for Yunzhisheng’s R&D and market expansion.
Notably, in 2023, Yunzhisheng launched its “Shanhai” large language model with 60 billion parameters, which has since evolved to a trillion-parameter scale. The company intends to apply this advanced technology to smart living and smart healthcare sectors, suggesting significant breakthroughs in AI innovation and commercial applications.
Despite a bumpy road to listing, Yunzhisheng’s technological accumulation in AI and its market potential, coupled with endorsements from heavyweight investors, instill confidence in its future development. As AI technology continues to evolve, Yunzhisheng is poised to realize greater commercial value in crucial sectors like smart healthcare and smart living.
【来源】https://www.chinastarmarket.cn/detail/1622638
Views: 1